Publisher: Icon Group International, Inc.
Category: Diseases & Conditions

Diseases & Conditions market research reports by Icon Group International, Inc.

(630 reports matching your criteria)
    • The 2025-2030 World Outlook for Cancer Therapies

      The 2025-2030 World Outlook for Cancer Therapies This study covers the world outlook for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Cancer Tumor Profiling

      The 2025-2030 World Outlook for Cancer Tumor Profiling This study covers the world outlook for cancer tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Carcinoembryonic Antigen

      The 2025-2030 World Outlook for Carcinoembryonic Antigen This study covers the world outlook for carcinoembryonic antigen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests

      The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests This study covers the world outlook for viral hepatitis and retrovirus diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2025-2030 World Outlook for Neurodegenerative Disorders

      The 2025-2030 World Outlook for Neurodegenerative Disorders This study covers the world outlook for neurodegenerative disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies

      The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies This study covers the world outlook for oncolytic virus immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Neuroendocrine Carcinoma

      The 2025-2030 World Outlook for Neuroendocrine Carcinoma This study covers the world outlook for neuroendocrine carcinoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Thalassemia Treatments

      The 2025-2030 World Outlook for Thalassemia Treatments This study covers the world outlook for thalassemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Immunotherapy Cancer Drugs

      The 2025-2030 World Outlook for Immunotherapy Cancer Drugs This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Colerectal Cancers

      The 2025-2030 World Outlook for Colerectal Cancers This study covers the world outlook for colerectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Mouse Models

      The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Mouse Models This study covers the world outlook for patient derived xenograft-PDX mouse models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Kidney Cancer Drugs

      The 2025-2030 World Outlook for Kidney Cancer Drugs This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics

      The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Alzheimer's Treatments

      The 2025-2030 World Outlook for Alzheimer's Treatments This study covers the world outlook for Alzheimer's treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Blood Plasma Fractionation

      The 2025-2030 World Outlook for Blood Plasma Fractionation This study covers the world outlook for blood plasma fractionation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments

      The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments This study covers the world outlook for basal cell carcinoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Bariatric (Obesity) Surgical Devices

      The 2025-2030 World Outlook for Bariatric (Obesity) Surgical Devices This study covers the world outlook for bariatric (obesity) surgical devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Clinical Vital Signs Monitoring Devices

      The 2025-2030 World Outlook for Clinical Vital Signs Monitoring Devices This study covers the world outlook for clinical vital signs monitoring devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Checkpoint Inhibitors

      The 2025-2030 World Outlook for Checkpoint Inhibitors This study covers the world outlook for checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings

      The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings This study covers the world outlook for fecal occult blood tests for in-vitro colorectal cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent dem ... Read More

    • The 2025-2030 World Outlook for Central Nervous System Lymphoma

      The 2025-2030 World Outlook for Central Nervous System Lymphoma This study covers the world outlook for central nervous system lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing

      The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing This study covers the world outlook for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Acute-Treatment Migraine Drugs

      The 2025-2030 World Outlook for Acute-Treatment Migraine Drugs This study covers the world outlook for acute-treatment migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Non-Hematological Cancer Treatments

      The 2025-2030 World Outlook for Non-Hematological Cancer Treatments This study covers the world outlook for non-hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Non-Hodgkin Lymphoma

      The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

4 5 6 7 8 9 10 11 12 13

Cookie Settings